Sign in to continue:

Thursday, July 30th, 2026

FDCTech, Inc. Files Restated Q2 2025 10-Q/A: Key Financial Corrections, Legal Updates, and Forward-Looking Statements 106

FDCTECH, INC. Files Restated Q2 2025 Results: Major Financial Corrections and Expanded Legal Disclosures

FDCTECH, INC. Files Restated Q2 2025 Results: Major Financial Corrections and Expanded Legal Disclosures

FDCTECH, INC. (OTC: FDCT) has filed an amended and restated Form 10-Q/A for the quarter ended June 30, 2025. This high-impact restatement follows the company’s determination that its previously filed financial statements for the period should not be relied upon due to multiple significant errors and omissions. The restatement introduces comprehensive revisions to the company’s balance sheet, income statement, and disclosures—moves that are highly relevant to shareholders and could materially affect the company’s valuation and share price.

Key Highlights from the Restated Report

  • Restatement of Financial Statements: FDCTECH has revised its financials for Q2 2025 as well as the comparative period, following the Board of Directors’ conclusion (after consulting with management and external auditors) that the prior filings contained material errors. The restatement is made in compliance with ASC 250 (Accounting Changes and Error Corrections).
  • Principal Restatement Items:
    • Reclassification of Subscription Receivable: A subscription receivable previously classified as a current asset has been reclassified to a contra-equity account, directly impacting the company’s equity reporting.
    • Unrecorded Common Stock Issuance: 500,000 shares of common stock issued in October 2021 were previously omitted from the share register. These are now recognized, impacting both share count and equity.
    • Separate Presentation of Restricted Cash: The company now separately presents restricted cash representing client funds segregated under regulatory requirements, improving financial transparency.
    • Corrections to Noncontrolling Interest and AOCI: Adjustments have been made to the noncontrolling interest walk (per ASC 810-10) and to the allocation of accumulated other comprehensive income (per ASC 220-10).
    • Reduction in Net Loss: Corrections to the results of operations—mainly within other income (expense)—reduced the net loss for the six months ended June 30, 2025 by \$207,915.
    • Segmental Cost of Sales Reclassification: Cost of sales has been reclassified between the Technology & Software and Brokerage segments.
    • Restatement of Client Funds: \$7.07 million of client funds at Alchemy Prime Limited and external third-party assets at Alchemy Markets Ltd. were reclassified from “Cash” to “Restricted cash — client funds (segregated)” with a corresponding adjustment in “Client funds payable.”
  • Expanded Legal Proceedings Disclosure: The report now contains expanded disclosures of legal proceedings, including new matters and updates as of June 30, 2025 and subsequent developments. These were not included in the original filing and may have material implications for the company.
  • Series of Related Restatements: Alongside this amendment, FDCTECH has also filed amendments to its 2024 and 2025 annual reports, and to other quarterly reports from March 2025 through March 2026, to ensure consistent restatement and legal disclosure across all recent filings.
  • Share Count and Capital Structure: As of June 8, 2026, the company had 423,084,729 shares of common stock outstanding, par value \$0.0001 per share.
  • Regulatory Compliance: FDCTECH confirms it is not a shell company and is fully compliant with its SEC reporting obligations.
  • Financial Statement Highlights (as restated):
    • Cash and cash equivalents as of June 30, 2025: \$2,316,508 (down from \$13,850,168 as of December 31, 2024)
    • Restricted cash (client funds, segregated): newly presented as a separate line item for transparency

Why This Matters to Shareholders

  • Potential Share Price Impact: The restatement of financial statements, particularly the correction of equity accounts, recognition of previously unrecorded stock issuances, and changes in net loss, are price-sensitive events. They directly affect the company’s reported financial health, capital structure, and potentially its compliance with regulations or covenants.
  • Legal Risks: The expanded legal proceedings disclosure introduces new information about potential or ongoing litigation and regulatory matters. These could pose future financial liabilities or operational uncertainties, and shareholders should pay close attention to the legal updates.
  • Transparency and Compliance: The company’s willingness to restate and expand its disclosures is a double-edged sword—while it may restore some confidence in transparency, it also raises questions about prior internal controls, governance, and the reliability of management’s past reporting.
  • Operational Segmentation and Client Asset Management: The reclassification of client funds and cost of sales between segments offers investors a clearer view of risk exposures and financial flows, especially in regulated environments for client asset custody.
  • Ongoing Restatements: The broad restatement across several reporting periods and filings signals deeper issues in FDCTECH’s prior financial reporting process, which could affect investor confidence.

What Investors Should Watch Next

  • Further details on the company’s remediation of internal controls and accounting processes.
  • Updates on legal proceedings that could result in material liabilities or settlements.
  • Market reaction to the reduced net loss and the impact of reclassifications on key financial metrics.
  • Management’s communication with shareholders regarding governance improvements and future outlook.

Conclusion

The filing of this restated 10-Q/A by FDCTECH, INC. marks a pivotal moment for the company and its investors. The breadth and depth of the corrections—ranging from core financial metrics to legal matters—make this a highly price-sensitive event. Investors are strongly advised to review the amended filings in detail and closely monitor the company’s subsequent disclosures and management commentary.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Readers should conduct their own due diligence and consult professional advisors before making any investment decisions. The author does not hold any position in FDCTECH, INC. at the time of publication.


View FDCTECH, INC. Historical chart here



Baxter International Inc. Q1 2026 Financial Results: Revenue, Earnings, and Key Financial Statements

Baxter International Inc. Q1 2026 Financial Results: Key Hig...